|
APOE
(HGNC:613)
|
lipoprotein glomerulopathy
(MONDO_0012725)
|
Definitive
|
|
|
ITGA3
(HGNC:6139)
|
epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
(MONDO_0013881)
|
Strong
|
|
|
IRX4
(HGNC:6129)
|
congenital heart disease
(MONDO_0005453)
|
Limited
|
|
|
IRF6
(HGNC:6121)
|
van der Woude syndrome 1
(MONDO_0007333)
|
Definitive
|
|
|
IRF6
(HGNC:6121)
|
tooth agenesis
(MONDO_0005486)
|
Limited
|
|
|
IRF5
(HGNC:6120)
|
systemic lupus erythematosus
(MONDO_0007915)
|
Definitive
|
|
|
IRAK1
(HGNC:6112)
|
systemic lupus erythematosus
(MONDO_0007915)
|
Strong
|
|
|
PDX1
(HGNC:6107)
|
maturity-onset diabetes of the young
(MONDO_0018911)
|
Moderate
|
|
|
PDX1
(HGNC:6107)
|
permanent neonatal diabetes mellitus
(MONDO_0100164)
|
Limited
|
|
|
PDX1
(HGNC:6107)
|
pancreatic agenesis
(MONDO_0009832)
|
Strong
|
|
|
FOXP3
(HGNC:6106)
|
immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome
(MONDO_0010580)
|
Definitive
|
|
|
ABCC9
(HGNC:60)
|
Brugada syndrome
(MONDO_0015263)
|
Limited
|
|
|
ABCC9
(HGNC:60)
|
dilated cardiomyopathy
(MONDO_0005021)
|
Limited
|
|
|
APOC2
(HGNC:609)
|
familial apolipoprotein C-II deficiency
(MONDO_0008810)
|
Definitive
|
|
|
INSR
(HGNC:6091)
|
insulin-resistance syndrome type A
(MONDO_0012520)
|
Strong
|
|
|
INSR
(HGNC:6091)
|
Donohue syndrome
(MONDO_0009517)
|
Definitive
|
|
|
INSR
(HGNC:6091)
|
Rabson-Mendenhall syndrome
(MONDO_0009874)
|
Strong
|
|
|
INS
(HGNC:6081)
|
permanent neonatal diabetes mellitus
(MONDO_0100164)
|
Strong
|
|
|
INSL3
(HGNC:6086)
|
cryptorchidism
(MONDO_0009047)
|
Moderate
|
|
|
INS
(HGNC:6081)
|
monogenic diabetes
(MONDO_0015967)
|
Strong
|
|